Insights Into The FDA's Guidance On Managing Drug Supply
Source: Life Science Leader
By Peter H. Calcott, Ph.D., FRSC, president and CEO, Calcott Consulting LLC
In April 2023, the FDA issued an updated guidance superseding and replacing the previous 2020 document about managing drug shortages and explaining what was expected of industry and how the agency was going to manage the shortfalls. The spirit of the original document remains, although certain details are changed to add clarity and to reflect current thinking.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more